Your session is about to expire
← Back to Search
Induction Chemotherapy for Esophageal Cancer
Study Summary
This trial is testing a new chemotherapy regimen to see if it can decrease the rate of cancer recurrence.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have moderate to severe nerve damage.I've been cancer-free for over 5 years or had certain skin or in situ cancers treated effectively.I do not have any chronic diseases that would interfere with the study's treatment.My blood tests show my organs are functioning well.My disease can possibly be removed with surgery.I am fully active or restricted in physically strenuous activity but can do light work.My cancer is confirmed to be in the esophagus, GE junction, or gastric cardia.I am not pregnant or nursing.I agree to use effective birth control.My cancer has spread to distant parts of my body.I am of childbearing age and might plan to have children.I am 18 years old or older.I have had chemotherapy, radiotherapy, or surgery for esophageal cancer.
- Group 1: Induction Chemotherapy /Chemoradiation
- All Individual Drugs Already Approved - Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
- Approved for 10 Other Conditions - This treatment demonstrated efficacy for 10 other conditions.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the FDA condone chemoradiation as a treatment method?
"Chemoradiation is a Phase 2 trial, so there is some data supporting safety but none supporting efficacy."
Chemoradiation is commonly used to treat which type of cancer?
"Chemoradiation is a common cancer treatment, but it can also be used to help patients with rectal carcinoma, advanced gastric cancer, and certain types of stem cell transplantation."
What is the cap on recruitment for this clinical research?
"This clinical trial is no longer recruiting patients. The study was first posted on June 19th, 2017 and was edited for the last time on August 17th, 2022. However, there are 1691 other studies currently enrolling patients that suffer from cancer of the esophagus and 287 trials actively admitting patients for chemoradiation."
Are there any current vacancies for this research project?
"According to the available information on clinicaltrials.gov, this study is not actively recruiting participants at this time. However, there are 1978 other trials that patients can participate in."
Are there other precedents for this type of Chemoradiation treatment?
"As of right now, there are 1691 ongoing clinical trials related to chemoradiation therapy. 509 of these studies are in phase 3. Most research is being conducted in Guangzhou, Guangdong; however, there are 88133 locations around the world investigating chemoradiation as a treatment option."
Share this study with friends
Copy Link
Messenger